Search company, investor...

Immunotope

immunotope.com

Founded Year

2003

Stage

Other Investors | Alive

About Immunotope

IMMUNOTOPE is a clinical stage biotechnology company developing immunotherapy products for the treatment and prevention of cancer and chronic viral infections. Our products activate the patient's own immune system to fight disease and prevent recurrence. Our comprehensive approach to cancer therapy focuses on the critical, unmet need to diagnose cancer at the very earliest stages and to develop effective treatments that destroy tumors and prevent metastasis.

Headquarters Location

The Pennsylvania Biotechnology Center 3805 Old Easton Road

Doylestown, Pennsylvania, 18902,

United States

Missing: Immunotope's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Immunotope's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Immunotope

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Immunotope is included in 1 Expert Collection, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Immunotope Patents

Immunotope has filed 1 patent.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Experimental cancer drugs
  • Immune system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/2/2017

2/19/2019

Immune system, Clusters of differentiation, Immunology, Transcription factors, Experimental cancer drugs

Grant

Application Date

3/2/2017

Grant Date

2/19/2019

Title

Related Topics

Immune system, Clusters of differentiation, Immunology, Transcription factors, Experimental cancer drugs

Status

Grant

Immunotope Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Immunotope Rank

Immunotope Frequently Asked Questions (FAQ)

  • When was Immunotope founded?

    Immunotope was founded in 2003.

  • Where is Immunotope's headquarters?

    Immunotope's headquarters is located at The Pennsylvania Biotechnology Center, Doylestown.

  • What is Immunotope's latest funding round?

    Immunotope's latest funding round is Other Investors.

  • Who are the investors of Immunotope?

    Investors of Immunotope include Mid-Atlantic Diamond Ventures, ImmunoVaccine Technologies and Ben Franklin Technology Partners of Central & Northern PA.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.